CBG authorized for use in cosmetics by the European Union
The European Commission has added cannabigerol (CBG) to the EU's cosmetic ingredients database (Cosing), meaning that this compound is safe for use in health and beauty products.
The CBG acts on the CB1 and CB2 endocannabinoid receptors located in the skin. Cannabigerol has anti-inflammatory, antibacterial and antioxidant properties that help the endocannabinoid system maintain healthy skin function.
Once CBG penetrates the epidermis, it reaches the basal and subcutaneous layers of the skin, where it helps calm inflammation, reduce blemishes, purify pores, balance sebum production and improve cell renewal.
CBG is known as the «mother» cannabinoid, the precursor of all other cannabinoids such as CBD, CBN, CBC or THC in their acid form.
CBD of natural origin, which has been added to the Cosing database at the beginning of the year, and synthetic CBD, are also authorized for use in EU cosmetics, just like hemp leaves.
CBG registration at Cosing can be seen here.
-
Business3 weeks agoNew York Opens Its Farmers' Markets to Small-Scale Cannabis Producers
-
Cannabis in Africa4 weeks agoRwanda: A New License Revives the Country's Ambitions in Medical Cannabis
-
Cannabis in India3 weeks agoIndia Approves a Synthetic CBD Drug for Anxiety
-
Cannabis in Europe4 weeks agoThe EU Simplifies Regulations Governing Hemp Cultivation
-
Cannabis in the U.S.3 weeks agoU.S. Congress Comes to the Rescue of THC-Infused Beverages
-
Business4 weeks agoCuraleaf Announces a Takeover Bid for Aurora Cannabis
-
Cannabis in Europe1 day agoAndorra Paves the Way for Medical Cannabis Cultivation
-
Cannabis in France3 days agoDrought: Could Hemp Become the New Hope for French Farmers?



You must be logged in to post a comment Login